ABI
STJ

Adamant Biomedical Investments’s St Jude Medical STJ Stock Holding History

Adamant Biomedical Investments’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3.32M Sell
51,000
-14,000
-22% -$902K 0.79% 46
2014
Q3 		$3.91M Buy
+65,000
New +$4.25M 0.98% 40

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Adamant Biomedical Investments's STJ Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its St Jude Medical (STJ) stake by 22% in Q4 2014, selling an estimated $902K and leaving 51,000 shares worth $3.32M. The position accounts for 0.79% of the portfolio, ranked #46.

Adamant Biomedical Investments first reported a position in STJ in Q3 2014 and has held it in 2 quarters since. The position peaked at $3.91M in Q3 2014. 591 funds tracked by Wall St. Rank hold STJ as of Q4 2014.

  • Adamant Biomedical Investments held 51,000 shares of St Jude Medical worth $3.32M as of Q4 2014.
  • Adamant Biomedical Investments sold 14,000 St Jude Medical shares in Q4 2014, an estimated $902K.
  • St Jude Medical made up 0.79% of Adamant Biomedical Investments's portfolio in Q4 2014, its #46 holding.
  • Adamant Biomedical Investments first reported a position in St Jude Medical in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's St Jude Medical position peaked at $3.91M in Q3 2014.
  • 591 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.